CJC-1295 (no DAC)
C152H252N44O423367.9 g/mol
CJC-1295 without DAC, also called modified GRF (1-29), is a synthetic 29-residue analogue of the 1–29 fragment of growth hormone-releasing hormone. It has four substitutions relative to the native sequence (D-Ala at position 2, Gln at 8, Ala at 15 and Leu at 27) and a C-terminal amide. Unlike CJC-1295 with DAC, it carries no maleimidopropionyl-lysine (drug affinity complex) at the C-terminus. Supplied as a lyophilised powder in a sealed glass vial. For laboratory research use only. Not for human or veterinary use.
At a glance
- Sequence
- H-YaDAIFTQSYRKVLAQLSARKLLQDILSR-NH2
- Amount
- 5 mg per vial
- Form
- Lyophilised powder
- Storage
- Store at -20 °C, sealed and protected from light
Full technical data
Specification
- Sequence
- Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2Calculate pI and charge
- Molecular formula
- C152H252N44O42
- Molecular weight
- 3367.9 g/mol
- Form
- Lyophilised powder
- Storage
- Store at -20 °C, sealed and protected from light
Names and identifiers
- Synonyms
- Modified GRF (1-29)
- Mod GRF 1-29
- CJC-1295 without DAC
- One-letter code
- H-YaDAIFTQSYRKVLAQLSARKLLQDILSR-NH2
Documents
- Safety data sheetOn request
References
- Cervini LA et al. (1998). Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studies. J Med Chem.
- Bai JP and Chang LL (1995). The involvement of dipeptidyl peptidase IV in brush-border degradation of GRF(1-29)NH2 by intestinal mucosal cells. J Pharm Pharmacol.
- Henninge J et al. (2010). Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation. Drug Test Anal.
How to cite this product
CJC-1295 (no DAC) (Amidae, United Kingdom; lot [lot number]). https://amidae.com/products/cjc-1295-no-dac
Add the vial size and the lot number from the vial label. Each lot's COA page gives the complete citation.
Structure
Hover a residueTap a residue
